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ABSTRACT 
WOULD NOT-FOR-CAUSE RANDOMIZED DRUG TESTING REDUCE  
 
THE INCIDENCE OF DRUG MISUSE AMONG CERTIFIED  
 
REGISTERED NURSE ANESTHETISTS? 
 
by Katy Gayle Gavin 
 
December 2015 
Healthcare providers have easy access to drugs of various types and strengths, 
often times highly addictive drugs, all the while working long hours in high stress 
environments.  Studies show that anesthesia providers, among other healthcare providers, 
are at highest risk for drug misuse.  There are numerous ways substance abuse and 
addiction among anesthesia providers could be decreased significantly or prevented 
completely including, but not limited to, education, routine mental health evaluations, 
stress coping through exercise, debriefing sessions, and mentoring.  This project focused 
on prevention through randomized not-for-cause drug testing.  After an exhaustive review 
of the literature was performed, implications for practice and suggestions were 
summarized in a white paper proposal, which will be presented to key stakeholders to 
include state and national governing bodies of the nurse anesthesia profession, anesthesia 
providers, students, and residents. 
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CHAPTER I 
INTRODUCTION 
It is estimated that 10% to 20% of nurse anesthetists will experience some sort of 
drug misuse during their career, with males practicing six to ten years being at highest 
risk (Bell, McDonough, Ellison, & Fitzhugh, 1999).  As cited by the American 
Association of Nurse Anesthetists (AANA, 2015), the incidence of drug misuse among 
anesthesia providers during their life is approximately 10%-17%.  Obtaining accuracy of 
the frequency of substance abuse among anesthesia providers is a difficult task.  This is 
because of the complex issues surrounding this topic, including legal issues, patient 
safety, and licensure, just to name a few.  According to Wright et al. (2012), the extent of 
the problem is more than likely larger than what is reported.  As a matter of fact, 
impairment while at work is probable, considering almost one out of every ten actively 
practicing Certified Registered Nurse Anesthetists (CRNAs) misuses a controlled drug 
(Bell et al., 1999).  It is important to determine the most effective ways in which to 
decrease the risk of chemical dependency among anesthesia providers, ultimately 
increasing patient safety and improving outcomes, not only for patients, but for 
anesthesia providers as well.    
Problem Statement 
 There are many factors that influence the development of substance abuse and 
dependency among providers, including genetics, personality, underlying psychiatric 
disorders, stress, access to drugs, and attitude, to name a few (Wright et al., 2012).  The 
high estimate of providers misusing drugs is alarming; therefore, preventative efforts and 
early intervention are imperative in decreasing the number of anesthesia providers 
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abusing narcotics and other potentially addictive drugs.  The impaired provider is not 
only at risk for causing medical errors resulting in poor patient outcomes, but also at 
increased risk for death due to overdose, either accidental or intentional.  “Attempted 
suicide or death by suicide or accidental overdose is not an infrequent presentation of 
addiction” (Saunders, 2006, p. 638).  The overwhelming evidence of misuse among 
anesthesia providers, coupled with the devastating outcomes of such, makes it imperative 
for a solution to be actively sought.    
Purpose of the Project 
With the high number of anesthesia providers estimated to be misusing drugs, or 
at increased risk for misusing drugs, impairment on the job is likely, and potentially fatal 
outcomes for both the provider and/or the patient are plausible.  The financial costs 
associated with an impaired provider are infinite.  A randomized not-for-cause drug 
screening may prevent misusing these highly addictive drugs due to the fact that 
providers could be randomly tested for drugs at any given time without displaying 
symptoms of being impaired and without preparation to adulterate the specimen.  This 
could potentially help decrease or possibly alleviate the unfortunate risk of drug misuse 
among anesthesia professionals, indirectly improving patient safety and outcomes.  
According to Wright et al. (2012, p. 126), in 2010, the American Association of Nurse 
Anesthetists’ model policy for random drug screening recommended “frequent random 
urine drug screening of small numbers of employees.”  However, the current position 
statement regarding “Substance Misuse and Chemical Dependency” is a “comprehensive 
for-cause drug testing program” (AANA, 2015, n.p.).  Therefore, the purpose of this 
capstone was to develop a white paper proposal for clinical implications of random not-
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for-cause drug screening and suggestions for possible future research.  The intention of a 
white paper is to promote a solution to a certain problem (The Writing Lab, The OWL at 
Purdue, & Purdue University, 2010).  In this instance, the problem is impaired anesthesia 
providers, and one of the proposed solutions is not-for-cause random drug testing.     
Clinical Question  
For the clinical question, the population (P) of interest is Certified Registered 
Nurse Anesthetists; the intervention (I) suggested is not-for-cause randomized drug 
screening; the comparison (C) is a pre-employment drug screening or for-cause screening 
if a provider displays symptoms of being impaired; and the outcome (O) is decreasing the 
risk of chemical dependency and the misuse of drugs among anesthesia providers.  The 
PICO question addressed is:  Would not-for-cause randomized drug testing reduce the 
incidence of drug misuse among Certified Registered Nurse Anesthetists?  
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CHAPTER II 
REVIEW OF LITERATURE  
Background and Significance 
 The disease of addiction may cause otherwise intelligent and rational individuals 
to do the unimaginable, but often times, these individuals are discreet in their actions.  
Drug misuse and chemical dependency among anesthesia providers have been an issue 
for many years.  Railroad workers, airline pilots, and commercial truck drivers are among 
the many professionals required by the United States Congress to submit to random drug 
testing to reduce the risk to the public.  Why then are not anesthesia providers held to the 
same standard when their primary responsibility is to do no harm to the patient? 
Arguments could be made for a number of reasons, including financial burdens for the 
employer, minimal signs and symptoms of impairment among anesthesia providers, and 
many more.  Unfortunately, abuse among anesthesia providers is often not recognized 
until death, or a near-death overdose has occurred (Wright et al., 2012).  Because of this 
terrifying statistic, it is crucial to develop policies and protocols with regards to drug 
testing, education, and prevention of abuse.   
So, why is death often times the first sign of chemical dependency among 
anesthesia providers? Is this because the potency of the drugs is so severe that one’s life 
can be taken quickly? Or is it because the professionals misusing these drugs are so 
highly educated and protective of their license, reputation, and financial security, they go 
to great lengths to hide the otherwise obvious signs and symptoms of addiction?  It is 
likely the combination of both of these reasons and more.  The anesthesia profession has 
increased stressors due to many variables, such as the demands of working long hours, 
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often times in critical, intense situations, and frequently, with minimal sleep.  Providers 
have easy access to powerful drugs, and are at an increased risk of substance abuse due to 
numerous factors.  As a matter of fact, more than any other group, physicians, nurses, and 
other healthcare providers are at higher risk for misusing drugs (Bell et al., 1999).  Of 
these, anesthesia providers have the highest risk of death due to drug-related causes 
(Wright et al., 2012).   
 There is a multitude of research available which shows that anesthesia providers 
are at an increased risk for chemical dependency, along with other healthcare providers, 
and workers in non-healthcare professions.  This information provides significant 
strength to this project.  An anticipated weakness of the project is a possible resistance to 
implementation of new policy and procedures possibly due to increased estimated costs.  
However, many opportunities exist if new policies related to random drug screening are 
implemented.  If drug misuse among providers is decreased, there could be countless 
lives saved, not only providers who could have potentially overdosed, but patients who 
could have been under the care of an impaired provider.  Financial losses could be 
avoided due to potential errors of an impaired provider, and financial gains are possible 
through improved work performance.  It may prove difficult to successfully implement 
preventative measures due to resistance of the stakeholders.  Costs may also be a factor 
threatening the success of the project due to limited funding for implementation of 
preventative programs such as not-for-cause drug testing.   
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Anesthesia 
In a 2005 study, it was hypothesized that anesthetics which were aerosolized, 
causing second-hand exposure to anesthetists, caused sensitization to the provider, and 
ultimately increased their risk for addiction (McAuliffe, et al., 2005).  Taking into 
account the stressors of the profession already put the provider at an increased risk to 
misuse drugs, the provider increases that risk even more by simply using drugs necessary 
to perform a successful anesthetic in the majority of procedures; therefore, education, 
prevention, and early intervention of drug misuse is imperative.  As a matter of fact, some 
would agree that education regarding chemical dependency should be implemented as 
soon as training begins.  In one study, a survey of anesthesia program directors found 
incidents of substance abuse among anesthesia students, where results included loss of 
nursing licensure, termination from the program, and even death (Bozimowski, Groh, 
Rouen, & Dosch, 2014).   
As referenced by Saunders (2006), a study performed by the Alcohol and Drug 
Research Centre in Edinburgh at the request of The Association of Anaesthetists of Great 
Britain and Ireland revealed  a “lack of awareness of schemes to deal with problems of 
alcohol and drug abuse within hospital trusts” (p. 638).  In many cases, providers are not 
tested for drugs until they are reported by a co-worker for displaying certain signs and 
symptoms of impairment.  According to the American Association of Nurse Anesthetists 
(AANA, 2015), some of the signs and behaviors to look for include, but are not limited 
to, isolation and withdrawal from peers, gradual decline in work performance, 
consistently signing out more narcotics than colleagues, frequent bathroom breaks, desire 
to take extra call, increased difficulty with authority, elaborate excuses, dishonesty over 
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trivial/unimportant matters, and patterns of inappropriate drug choices and dosages, 
among others.   
The AANA (2015) emphasizes knowledge of signs and behaviors of an impaired 
provider is vital; however, the AANA also recognizes that identifying impairment in a 
colleague is difficult.  This may be due to the fact that these changes in behavior may not 
be abrupt.  According to the AANA, as cited in Luck and Hendrick (2004), these 
behavior changes may occur little by little, over the course of months or years, making 
them complicated to identify.  There are multitudes of ways impaired providers may 
conceal their addiction from others.  Addicts may alter their charting to show certain 
drugs were given, when in fact, another drug was given, or sometimes, to the detriment of 
the patient, none were given at all; some addicts may replace their drug of choice with 
another liquid, leaving the vial as if it had never been tampered with or accessed at all 
(Bryson & Silverstein, 2008).  Anita Bertrand, a Certified Registered Nurse Anesthetist 
practicing in Houston, stated, “I was absolutely impaired, using narcotics while 
working…And no one ever noticed;” she even placed an intravenous port in her ankle for 
easier access to administer her drug of choice (Eisler, 2014).  Bertrand stated, “There are 
so many practitioners working impaired and we have no idea…we’re doing a terrible job 
addressing this problem” (Eisler, 2014).   
   Another example of how anesthesia providers may be misusing drugs and going 
undetected is abusing drugs not typically accounted for by the pharmacy, unlike 
controlled drugs such as narcotics.  For example, in a survey of 126 anesthesia residency 
programs, 18% of the departments had documented accounts of the anesthetic drug, 
propofol being misused, and seven reports of death due to propofol abuse (Wischmeyer et 
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al., 2007).  In another survey of members of Anesthetists in Recovery, almost one-third 
admitted to injecting themselves with propofol on at least one occasion (Stocks, 2011).  
Intravenous drugs are not the only non-controlled drugs of abuse; according to a survey 
by Wilson et al. (2008), 22% of respondents reported one or more persons abusing 
inhalational anesthetics, with 26% of those resulting in death.  According to this same 
report, there was no pharmacy accounting of inhalational anesthetics by a majority of the 
anesthesia departments (Wilson et al., 2008).       
Nursing 
The incidence of drug misuse among the nursing profession is profound.  Looking 
at one example of the severity at the state level puts the issue into perspective.  On 
average, approximately 300 nurses yearly are disciplined by the Alabama State Board of 
Nursing for having substance misuse problems, as cited by Monroe, Vandoren, Smith, 
Cole, and Kenaga (2011).  One study found that an estimated seventeen thousand nurses 
in the United States were identified with substance abuse problems in a one year period 
(Monroe, Kenaga, Dietrich, Carter, & Cowan, 2013).  This is an overwhelming and 
frightening statistic as these individuals are charged with caring for the public.    
In 2012, as cited by New (2014), a nurse received a prison sentence because of 
her diversion of drugs.  This nurse had replaced hydromorphone with normal saline, and 
by doing so, the nurse caused twenty-five people to become infected with a blood borne 
pathogen (New, 2014).  Some of these patients were in critical condition, some required 
surgery, and one person lost their life (New, 2014).  Ultimately, nurses are threatening the 
safety of those they care for as well as themselves when they divert drugs.  It is vital for 
governing bodies, from the national level to the individual institution, to have strict 
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policies and procedures in place to prevent or maximally decrease the incidence of drug 
misuse.   
Medical Professionals 
The disease of addiction is not limited to anesthesia providers and nursing staff.  
Fung and Lange (2011)cited references estimating 6-10% of dentists were chemically 
dependent.  In 2009, an investigation into an outbreak of the hepatitis C virus began in 
Colorado (Warner et al., 2015).  This investigation would eventually reveal that a 
hepatitis C positive surgical technician was taking syringes of fentanyl from unattended 
anesthesia carts, self injecting, refilling the same syringe with saline, and then returning 
the syringe to the cart (Warner et al., 2015).  According to Warner et al. (2015), another 
incident involving an outbreak of hepatitis C in New Hampshire identified a traveling 
radiology technician as the source. 
Hamza and Bryson made a profound statement in their 2012 publication: “Opioid-
addicted health care providers are masters of drug diversion.  Education does not grant 
anybody immunity from developing addiction, and in this population, intelligence can be 
used to cleverly circumvent narcotic accountability and drug substitution” (p. 266).  
Because of this subtle and manipulative behavior, it is crucial that drug testing protocols 
be implemented.  In a survey of 1,891 medical physicians, over 300 reported being 
directly aware of a physician associate who was under the influence or not competent to 
practice medicine (DesRoches et al., 2010).  Sixty-seven percent of those with that 
knowledge stated that the impaired physician was the one to whom they would otherwise 
report (DesRoches et al., 2010.  When faced with these types of situations, many do not 
report.  The top three reasons for not reporting, according to the study by DesRoches et 
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al. (2010), were thinking that another person had taken care of it, thinking reporting the 
problem wouldn’t make a difference, and apprehension of retaliation.  Knowing that 
many practitioners recognize signs and symptoms of impairment but still choose not to 
act, makes it all the more essential to implement randomized drug testing. 
Non-Healthcare Professionals 
Chemical dependency and drug abuse are not limited to healthcare professionals.  
The United States Congress implemented an act for mandatory testing of transportation 
employees with safety sensitive functions after major incidents occurred, such as the 
Exxon Valdez oil spill, thus bringing much needed public attention to this serious issue 
(Li, Brady, DiMaggio, Baker, & Rebok, 2010).   Consider the results of the random 
testing performed by the Federal Aviation Administration during 1995-2005.  There were 
over half a million alcohol tests performed, with 601 alcohol violations and over one 
million drug tests performed, with 7,211 drug violations (Li et al., 2010).  These were a 
small percentage of positives considering the number of individuals tested, but the 
consequences of not detecting these individuals could have been catastrophic.     
Li et al. (2011) also state general aviation, which consists of non-commercial 
flights, account for more than 90% of all flight accidents and deaths.  These general 
aviation flights are not covered by the mandatory drug-testing programs (Li et al., 2011).  
Therefore, one could conclude statistics involving drug related aviation accidents do not 
accurately depict the data.  Other transportation employees affected by drug-testing 
included commercial drivers.  They have a significantly higher rate of impairment 
compared to aviation.  In a 2009 study of over sixty-six thousand fatal multi-vehicle 
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crashes, almost 20% of non-motor carrier drivers tested positive for alcohol in a blood 
test (Brady et al., 2009).    
Drug Testing 
According to Eisler (2014), hospitals and other health care facilities rarely 
perform random drug testing, and there are no state laws that require it.   With this 
knowledge, chemically dependent individuals who misuse drugs may feel they are at a 
decreased risk of being tested, and ultimately, a decreased risk of being caught misusing.    
There are many pros and cons of random not-for-cause testing.  One of the pros of a 
randomized screen is there would be a decreased risk of a provider cheating the test when 
there is no prior knowledge of such a test.  According to Cholakis and Bruce (2007), most 
workplace drug testing is performed prior to the provider beginning work, and this type 
of testing generally uses a traditional urinalysis; knowing this, drug abusers may stop 
using detectable drugs in an adequate amount of time before the test, then begin using 
again after they pass the test.  An Internet search of the phrase beat drug test in July 2015 
resulted in over thirteen million hits; cheating drug tests has become a real issue.  
Between May 2004 and April 2005, about 10,000 specimens tested in certified labs were 
“found to be adulterated, substituted, or invalid” (Bush, 2007, p. 116).  This isn’t 
surprising considering the availability of products to do such.   
There are numerous products available to alter results of drug screens, not only 
for urine, but other bodily specimens as well.  There are shampoos available for hair 
samples, mouthwashes for oral fluid samples, and for blood, there are “whole body 
cleansers” (Bush, 2007, p. 116).  Because of these products readily available on the 
market, random drug screening may be more appropriate in detecting drug abuse.  
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Random drug screening may not only help with prevention, it may also benefit those who 
have already been chemically dependent.  There are improved outcomes of recovery 
when random drug screening is performed among recovering physicians, seemingly due 
to the repercussions of not passing the drug screen (Fitzsimons, Baker, Lowenstein, & 
Zapol, 2008).  It is important to monitor these individuals in the recovery process, not 
only with random drug screening, but also with routine mental screening.  In a study of 
health care professionals with substance abuse disorders by Domino et al. (2005), the 
presence of a co-existing psychiatric illness significantly increased the likelihood of 
relapse.  These individuals are at an increased risk for reverting back to drug diversion, 
and therefore would benefit greatly from random drug screening.    
The financial burdens are more than likely one of the top negative aspects 
associated with drug testing, as it can result in significant costs to the employer.  
However, random testing can identify individuals who may not necessarily exhibit the 
classic signs and symptoms, and may ultimately save lives and dollars.  In a study 
analyzing over 15,000 households, findings suggested that drug-testing programs 
deterred some potential drug-using employees, but may also decrease morale and 
discourage productive employees (French, Roebuck, & Alexandre, 2004).  Drug testing 
programs which deter potential drug users can also come at a cost.  To put an exact 
number on the cost, of course, is nearly impossible due to the variables and 
considerations.  In 2006, however, the effectiveness and benefit-cost ratio was analyzed 
in a transportation company with a peer-based substance abuse program (Miller, 
Zaloshnja, & Spicer).  The findings in this particular situation showed an estimated 
$1,850 savings per employee in avoided injury costs due to the program.  Therefore, in 
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this instance, the peer-based program in conjunction with random testing proved to be 
cost-effective in the workplace (Miller, Zaloshnja, & Spicer, 2006).  
A few variables to consider when it comes to cost-benefit of an impaired 
anesthesia provider would be the costs of medications redirected from the patient, the 
cost of unfavorable outcomes of a patient if the impaired provider made a medical error, 
costs of lost labor from days off of work, and the costs of the drug testing just to name a 
few.  Bryson and Silverstein (2008) quoted costs from a laboratory in New York state 
charging $32.50 to test for fentanyl in a urine sample, and $290 to test for propofol in a 
urine sample; the cost for testing hair samples can be over a thousand dollars.  However, 
with the short half-lives of many commonly abused drugs, hair analysis is often time the 
best choice for detecting chronic drug misuse (Kintz, Villain, Dumestre, & Cirimele, 
2005).  Costs for the employer are not only incurred through testing, however, chemical 
dependency costs businesses in other ways.  The cost to a business on average is about 
$10,000 per drug user due to decreased productivity, missing work with greater than ten 
absences, and increased insurance rates (Cholakis & Bruce, 2007).  As for healthcare 
facilities, the Centers for Medicare and Medicaid Services (2004) can terminate services 
if a diversion case involving patient harm leads to Immediate Jeopardy.          
According to a report published in 1999 by the Institute of Medicine, operating 
rooms were one of the places within a hospital where high error rates were most likely to 
occur.  This not only resulted in an estimated total national cost between $17 billion and 
$29 billion per year, but perhaps more importantly, in the loss of human lives.  The 
impairment of the anesthesia provider significantly increases the risk for a compromise in 
patient safety and error in the operating room (Wright et al., 2012).  Of all healthcare 
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providers found misusing drugs, anesthesia providers have the highest risk of death due 
to drug-related causes (Wright et al., 2012).  The costs associated with addicted 
anesthesia providers are high for all parties involved, including the provider, the patient, 
the employer, the patient’s families, and even colleagues of the impaired provider. 
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CHAPTER III 
CONCEPTUAL AND THEORETICAL FRAMEWORK 
Analysis of the Nursing Process Theory and Capstone Fit 
The explanatory theory is a middle-ranged theory designed to build knowledge; it 
“identifies how the properties and components relate to one another and accounts for the 
functions of the discipline” (Purnell, 2011, p. 526).  This theory was utilized to explain 
not only the association of risk factors of chemical dependency to the profession of 
anesthesia, but how random drug testing may decrease that risk.  Furthermore, as a 
doctoral prepared anesthesia provider, the intent was to provide knowledge to other 
anesthesia providers of the signs and symptoms to look for in an impaired anesthetist in a 
collaborative effort to further decrease risks of chemical dependency to anesthetists.  I 
also provided knowledge of what the literature shows and provided implications of 
practice, as well as suggestions for further research, to the key stakeholders in the form of 
a white paper analysis. 
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CHAPTER IV 
METHODOLOGY  
Target Outcome 
The primary objective of this capstone project was to determine if a not-for-cause 
random drug testing protocol would be beneficial in reducing the number of anesthesia 
providers who misuse drugs, and/or decrease the risk for those who are not actively 
misusing.  The target outcome was to develop a white paper/policy proposal and 
eventually present to key stakeholders who could ultimately implement a policy change 
for drug testing among anesthesia providers.  Results of the project are to be presented to 
those who could benefit from this knowledge. An exhaustive review of literature was 
performed to answer the PICO question, “Would not-for-cause randomized drug testing 
reduce the incidence of drug misuse among Certified Registered Nurse Anesthetists?”  
Research not only focused on the literature of the target population, but it also observed 
the literature related to drug misuse among other healthcare providers and employees in 
professions outside of the healthcare industry.  Once this data was gathered and analyzed, 
a set of best practice guidelines and future research recommendations were established.  
In the form of a white paper analysis, these are to be presented to key stakeholders, such 
as state and national governing bodies, anesthesia providers, and students, for 
consideration. 
Population 
 During the literature review process several populations were studied.  The main 
population of focus with this capstone project was Certified Registered Nurse 
Anesthetists.  Other populations studied were professions who affected the general public 
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such as nursing, other healthcare providers, and transportation entities.  Although the 
study results were centered on anesthesia providers, the findings could be potentially 
implemented in all areas of healthcare and other professions, given that chemical 
dependency is a disease that does not discriminate. 
Methods 
An extensive and thorough literature review was conducted.  Literature was 
obtained from the following databases: Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), American Association of Nurse Anesthetists online research, 
Medline, Google Scholar, Academic Search Premier, and PubMed.  After the results were 
compiled, a white paper proposal of best practice guidelines for drug testing for 
prevention of chemical dependency was developed.  These guidelines can be utilized by 
stakeholders, including state and national governing bodies for nurse anesthetists, 
anesthesia providers, students, and the families of providers. 
  
18 
 
 
 
                     
CHAPTER V 
IMPLICATIONS 
 Anesthesia providers do not have a set of best practice guidelines established with 
regards to not-for-cause random drug testing.  Evidence shows anesthesia providers are at 
the highest risk for chemical dependency than any other healthcare provider, and on-the-
job impairment could have devastating and fatal outcomes for both the patient and 
provider.  Established guidelines for random drug testing have the potential to 
significantly decrease the risk for addiction as well as decrease the number of on-the-job 
impaired providers and improve patient outcomes.  This research could also set the 
foundation for future research related to drug testing.  This, in turn, could ultimately 
improve patient safety and patient outcomes, decrease costs, and save lives.  If 
successful, these policies could potentially be implemented into other areas of health care 
as well, including physicians, nursing, radiology, and other ancillary staff.  After 
thorough review of the literature, a white paper analysis was developed for presentation 
to stakeholders including state and national governing bodies, anesthesia providers, 
students, residents, and families of providers. 
 Evidence-based practice will be used to facilitate change.  For this capstone 
project, Stetler’s model of Evidence Based Practice was the applied model.  This model 
involves five steps which include preparation, validation, comparative 
evaluation/decision making, translation/application, and evaluation (Ciliska et al., 2011).  
The first phase consisted of recognizing and establishing a superior need, which in this 
case was the prevalence of impaired anesthesia providers.  The next phase involved an 
exhaustive review of the literature and assembling evidence related to the need.  After 
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that, the data was evaluated, and key points were noted and determined to be essential in 
providing evidence to implement change.  Subsequently, the evidence was compiled and 
a white paper analysis was developed.  Once this analysis is submitted to key 
stakeholders mentioned, if change is implemented, an evaluation of the recommendations 
will take place.   
Barriers 
There could potentially be several barriers faced when attempting to present this 
capstone project to key stakeholders.  Resistance to change policies may be a factor.  
Another possible issue would be the perceived costs of implementing programs for 
randomized drug testing.  There may also be arguments against random drug testing due 
to the potential of unfair testing procedures and protocols.  Through support of the 
literature and cost benefit analysis, prospective obstacles may be avoided when presented 
to the stakeholders, which will include state and national governing bodies, anesthesia 
providers, and students.   
Implications for Practice 
If these guidelines and recommendations are implemented, and demonstrate 
success in decreasing addiction risks, identifying impaired anesthetists, and preventing 
addiction, then it is hopeful that the future generation of anesthesia providers will 
experience a decreased incidence of drug misuse.  Furthermore, with the combination of 
education and drug testing data, which would be obtained from implementation in the 
anesthesia profession, similar drug testing programs among other disciplines of nursing 
and healthcare could develop.  The process of random drug testing, as we know it could 
potentially change.  The cost benefits of different types of testing for certain drugs could 
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be researched further.  Urine sampling may no longer be the norm, and oral fluid or hair 
samples may be the new samples of choice with randomized drug screening for 
healthcare providers and other disciplines.  Further research may also be implemented as 
a result of this white paper proposal, including further studies related to the risk factors 
associated with chemical dependency, implementation of programs counseling high-risk 
individuals, addiction education during anesthesia school, and randomized drug testing 
during school just to name a few.  The potential changes could significantly improve 
work performance, decrease medical errors related to impaired providers, and improve 
patient safety and outcomes in all areas of healthcare.   
There are endless possibilities for future implications for practice and further 
research.  Bryson and Silverstein cited a study performed in 1990 of a report of 180 cases 
of substance abuse among anesthesiology residents, where thirteen died as a result of 
relapse (2009).  Individuals who have a prior history of abuse have an increased risk of 
relapse and the risk increases further with each relapse (Domino et al, 2005).  According 
to a study by Wright et al. (2014), random drug testing was noted to be a “definite 
deterrent to using” (p. 72).  Perhaps, randomized drug testing for those in recovery should 
be more frequent than what is currently required.   
Other possible implications to consider would be policy changes at various levels.  
According to the Re-Entry Recommendations and Resources of the American 
Association of Nurse Anesthetists (AANA, 2015), a monitoring program of a minimum 
of five years is recommended as part of recovery.  One suggestion based on the current 
literature would be for mandatory randomized drug testing for the remainder of the 
individual’s career in anesthesia, and on a more frequent basis than the non-recovering 
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provider.  Another recommendation to consider would be permanently revoking licensure 
if individuals are caught misusing drugs while in recovery.  This would alleviate the risk 
of relapse, and perhaps even death of the provider.    
Other policy changes may include the pharmacy department protocols at the 
institutional level.  One study suggests using an analysis of unusual drug transactions to 
detect diversion of drugs (Epstein, Gratch, & Grunwald, 2007).  Other considerations are 
having policies in place to handle discrepancies, validating and identifying controlled 
medications returned to pharmacy, and frequently auditing charts.  One way of validating 
and identifying medications is through a refractometer.  Refractometers are a reasonably 
priced and practical technique of drug diversion recognition which can be done on-site 
with instant results (O’Neal, Bass, & Siegel, 2007).  Depending on the institution size and 
staff, policy implementations may differ, but it is critical to have some form of drug 
diversion policy in place to reduce the incidence of misuse among providers.     
  
22 
 
 
 
                     
CHAPTER VI 
FULFILLMENT OF THE EIGHT ESSENTIALS OF THE DOCTORAL EDUCATION 
FOR ADVANCED NURSING PRACTICE  
The DNP Essentials Encompassed 
Essential I. Scientific Underpinnings for Practice (Chism, 2013) 
 Essential one was met by identifying successful ways to decrease risks of 
chemical dependence encountered by nurse anesthesia providers though drug testing 
strategies.  This project also met this essential by encompassing sciences of therapeutics, 
psychosocial sciences, and human biology; it focused on how providers interact with 
their environment in normal life situations and in critical events (AACN, 20006). 
Essential II. Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking (Chism, 2013) 
 According to the American Association of the Colleges of Nursing (AACN), 
Doctorate of Nursing Practice (DNP) graduates must be adept in quality improvement 
practices and in establishing and maintaining changes, not only at the institutional level, 
but at the policy level as well (2006).  Essential two focused on quality improvement and 
systems thinking by decreasing the risk for chemical dependency, by providing specific 
drug testing policy recommendations, and ultimately improving patient outcomes.   
Essential III. Clinical Scholarship and Analytical Methods for Evidence-Based Practice 
(Chism, 2013) 
 Essential three was met through an integrated literature review and analysis of 
evidence-based guidelines which helped to establish a white paper proposal for a best 
practice policy change.  By incorporating knowledge gained from other disciplines 
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regarding chemical dependency, connections were made, and meaning was given to a 
series of isolated data and facts, which might not have been connected otherwise.  This 
further advanced the understanding of drug testing policies among the anesthesia 
profession (AACN, 2006). 
Essential IV. Information Systems/Technology and Patient Care Technology for the 
Improvement and Transformation of Health Care (Chism, 2013) 
 Information systems and technology was utilized by accessing databases to gather 
research to complete the literature review. 
Essential V. Health Care Policy for Advocacy in Health Care (Chism, 2013) 
 Essential five was addressed through advocating for wellness of the healthcare 
providers, thus, ultimately improving patient safety and outcomes as a result.   In 
addition, by educating stakeholders regarding patient outcomes and potential policy 
changes, this essential was met (AACN, 2006). 
Essential VI. Interprofessional Collaboration for Improving Patient and Population 
Health Outcomes (Chism, 2013) 
 Collaborating with other healthcare providers through debriefing and educating 
them on the signs and symptoms of impaired colleagues, there is a potential to ultimately 
improve patient outcomes by decreasing the risk of impaired providers.  Through 
effective communication and in developing guidelines regarding random drug testing, 
essential VI was addressed (AACN, 2006). 
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Essential VII. Clinical Prevention and Population Health for Improving the Nation’s 
Health (Chism, 2013) 
 The AACN cites Allen, et al., stating “clinical prevention is defined as health 
promotion and risk reduction/illness prevention for individuals and families” (2006).  By 
providing guidelines for drug testing and recommendations for preventing the risk for 
chemical dependency, essential seven was fulfilled.   
Essential VIII. Advanced Nursing Practice (Chism, 2013) 
 According to the AACN, DNP graduates should base their practice on the 
application of multiple sciences and should exhibit distinguished assessment skills 
(2006).  This essential was met due to the fact that the project covers a multitude of 
sciences, including psychosocial, behavioral, cultural, economic, and nursing sciences.  
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APPENDIX B 
LITERATURE REVIEW TABLE 
 
Author/ 
Date 
Study Type Sample Methodology Conclusions 
Bell, D. M.,  
McDonough, J., 
Ellison, J.S., & 
Fitzhugh, E.C.  
(1999) 
 
 
Quantitative n=1709 actively 
practicing CRNAs 
Mailed surveys to 
AANA members; Chi-
square test 
Addiction education 
should be mandatory in 
anesthesia schools; most 
CRNAs feel their 
colleagues who 
successfully complete 
rehab should be permitted 
to re-enter the profession; 
however, after a relapse, 
most believe re-entry 
should be denied. 
Bozimowski, G., 
Groh, C., Rouen, 
P., & Dosch, M. 
(2014) 
Cross-sectional 
retrospective study 
n=47 program directors  
n=23 of the 47 with 
complete data 
Electronic survey mailed 
to program directors 
asking for current data 
and data within the 
previous five years 
Substance abuse among 
SRNAs is of concern; 
future research would be 
useful.  Some limitations, 
include limited analysis 
due to descriptive data; 
response rate of 21.7%, 
and possible missing, 
undocumented, or 
overlooked incidents of 
substance abuse. 
  
 
2
7
 
Brady, J.E., Baker, 
S.P., DiMaggio, 
C., McCarthy, 
M.L., …, & Li, G. 
(2009) 
Quasi-experimental 
design 
n=66,138 crashes 
 
Study involved pre- and 
post-implementation 
time periods of 
mandatory alcohol 
testing programs 
including motor carrier 
& non-motor carrier 
drivers 
Results indicate 
implementation of 
mandatory alcohol testing 
programs associated with 
23% decrease in alcohol 
involvement in deadly 
crashes by motor carrier 
drivers. 
DesRoches, C.M., 
Sowmya, R.R., 
Fromson, J.A., 
Birnbaum, R.J., 
Iezzoni, L., Vogeli, 
C., & Campbell, 
E.G. (2010) 
Quantitative n=1891 Survey of physicians to 
determine experiences, 
beliefs, and readiness to 
report colleagues who 
were under the influence 
or incompetent to 
practice 
More than half of 
respondents indicated they 
agreed with need to report, 
but most who had 
knowledge of impaired 
colleagues did not report 
for various reasons. 
Domino, Hornbein, 
Polissar, Renner, 
Johnson, …, & 
Hankes 
( 2005) 
 
 
 
Retrospective cohort  n=292 chemically 
dependent health care 
professionals 
Information retrieved 
from database of 
treatment facility over a 
ten year period 
Risk of relapse with 
substance use increased in 
major opioid use, a co-
existing psychiatric 
illness, or family history 
of substance use disorder.  
Presence of more than 1 
risk factor & previous 
relapse increased chances 
of relapse further. 
  
 
2
8
 
Epstein, R.H., 
Gratch, D.M., & 
Grunwald, Z. 
(2007) 
Data analysis and 
record audit 
n=2 cases where diversion 
was known, using data 
mining approach, trends 
were identified 
Graphical approach used 
to find outliers, & 
manual audits of 
transactions assessed 
drug diversion 
Identifying unusual drug 
transactions (frequent 
transactions on patients 
after surgery or obtaining 
drugs off site of 
procedure) using 
automated drug dispensing 
machines is useful in drug 
diversion detection 
Kintz, P., Villain, 
M., Dumestre, V., 
& Cirimele, V.  
(2005) 
 
 
 
Case Control  n=4 cases of 
anesthesiologists addicted 
to fentanyl derivatives 
Requested testing for 
anesthesia agents in four 
legal cases, hair samples 
were taken.  Three cases 
were suspected of 
addiction, the fourth was 
post-mortem. 
Usually, blood and/or 
urine collected at 
inadequate times & not 
useful to document 
impairment; hair testing 
should be used as 
complement to increase 
window of drug detection.  
Collection of the sample is 
non-invasive, can be done 
under close supervision, & 
storage at room 
temperature. 
Li, G., Baker, S.P., 
Zhao, Q., Brady, 
J.E., Lang, B.H., 
…, & DiMaggio, 
C. (2011 
Retrospective ten 
year study  
n=4977 post-accident 
drug tests 
n=1,129,022 random drug 
tests 
Case-control analysis Aviation employees much 
less likely to use illicit 
drugs than other 
transportation modes & 
the general workforce.  
However, study limited to 
employees of major 
airlines, commuter air 
carriers, & air taxis.  
  
 
2
9
 
Li, G., Brady, J., 
DiMaggio, C., 
Baker, S., & 
Rebok, G. (2010).   
Retrospective 
ten year study 
n=649,796 random 
alcohol tests 
n=1,129,922 random 
drug tests 
n=2284 for-cause alcohol 
tests 
n=2015 for-cause drug 
tests 
Positive Predictive 
Values  
More difficult to detect a 
person under the influence 
of illicit drugs than a 
person under the influence 
of alcohol based on 
physical appearance, body 
odor, behavior, & job 
performance.  Limited 
accuracy of suspected 
alcohol & drug violations 
is due in part to low 
prevalence of alcohol & 
drug use in aviation 
employees. 
Monroe, T.B., 
Kenaga, H., 
Dietrich, M.S., 
Carter, M.A., & 
Cowan, R. (2013) 
Qualitative analysis n=59 member boards 
n=128 nurses per board 
Modified balanced 
stratified sampling 
technique of a survey of 
regulatory boards 
disciplinary monitoring 
programs 
Prevalence of nurses with 
recognized substance use 
problems= 17,085. 
Prevalence of nurses 
enrolled in disciplinary 
monitoring programs= 
12,060.  Limitations of 
convenience samples 
include recruitment bias & 
limited generalization.   
  
 
3
0
 
Warner, A.E., 
Schaefer, M.K., 
Patel, P.R., 
Drobeniuc, J., Xia, 
G.,…, Thompson, 
N.D. (2015) 
Patients were 
identified through 
health records at the 
facilities where the 
tech was employed, 
and were contacted 
with a letter 
informing them of 
their potential 
exposure to hepatitis 
C 
n=5970 patients were 
identified who could have 
possibly been exposed 
Pairwise genetic 
distances of nucleotide 
quasi-species sequences 
were estimated with the 
DNADIST program in 
the PHYLIP package. 
Differences in the 
distributions of the 
HVR1 genetic distances 
were compared using the 
ANOVA program. 
18 confirmed cases of 
hepatitis C transmission 
due to diversion of 
surgical technician.  The 
technician was sentenced 
to 30 years in prison. 
Wilson, J.E., 
Kiselanova, N., 
Stevens, Q., Lutz, 
R., Mandler, T., 
Tran, Z.V., & 
Wischmeyer, P.E. 
Quantitative study  n=106 surveys completed 
from anesthesia 
departments 
Anesthesia department 
chairs responded to 
online surveys. 
22% of anesthesia 
departments responding to 
surveys reported abusing 
inhalational anesthetics.  
26% found misusing had 
fatal outcomes.  
Weaknesses: uncertain 
recall of incidences 
including inhaled 
anesthetics, departments 
that did not respond to 
survey may have had 
incidences of misuse, & 
respondents may not have 
included cases occurring 
before they arrived to 
department.   
 
 
  
 
3
1
 
Wischmeyer, P.E., 
Johnson, B.R., 
Wilson, J.E., 
Dingmann, C., 
Bachman, H.M., 
…, Henthorn, T.K. 
(2007). 
Descriptive  n=93 anesthesia program 
departments 
Descriptive analysis of 
emailed surveys 
Took into account 
propofol abuse among all 
anesthesia personnel 
within the departments 
including attendings, 
residents, and CRNAs.  
Data may not be accurate 
for several reasons 
including propofol not 
being routinely tested in 
urine drug screens, and 
many case reports 
discovered propofol abuse 
only after death or when 
the individual was found 
unconscious. 
Wright, E.L., 
McGuinness, T., 
Schumacher, J.E., 
Zwerling, A., & 
Moneyham, L.D. 
(2014) 
Qualitative Inquiry n= 6 
nurse anesthetists who had 
experienced anesthetic 
opioid dependency, 
undergone treatment, dealt 
with regulatory sanctions 
against their license, could 
not practice for at least 8 
months, and successfully 
returned to anesthesia 
practice 
 
Participants were 
recruited through online 
advertising; data were 
collected through 
semistructured 
individual telephone 
interviews 
All participants agreed 
continual involvement in a 
Twelve-Step program was 
vital to their recovery.  
The need for trigger 
management was also an 
important factor.  All 
participants agreed 
random urine drug 
screening was a deterrent 
to using. 
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